Scientific Advisory Board

Research Down Syndrome supports research at leading institutions that are studying the basis of the intellectual impairments associated with Down syndrome. The funding supports internationally recognized scientists and clinicians based on recommendations by our Scientific Advisory Board (SAB). The SAB is comprised of highly distinguished and accomplished researchers and clinicians in the area of Down syndrome and related biomedical research fields.

The Scientific Advisory Board includes

Ronald M. Evans, Ph.D.

Ronald M. Evans, Ph.D. is a Professor and Director of the Gene Expression Laboratory at the Salk Institute for Biological Studies. He is a Howard Hughes Medical Institute Investigator and the March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute.

Dr. Evans received both his B.A. in Bacteriology and his Ph.D. in Microbiology and Immunology from the University of California, Los Angeles, and was a Postdoctoral Fellow at Rockefeller University.

A member of the National Academy of Sciences, Dr. Evans is the recipient of the 2003 March of Dimes Prize in Developmental Biology, the 2004 Albert Lasker Award for Basic Medical Research, the 2005 the Grande Médaille of the French Academy of Sciences, the 2006 Harvey Prize, the 2006 Gairdner Foundation International Award, the 2007 Albany Medical Center Prize and the 2012 Wolf Prize in Medicine.

His research focuses on the function of nuclear hormone signaling and metabolism.

Leslie Leinwand, Ph.D.

Leslie Leinwand, Ph.D. is a Molecular, Cellular, and Developmental Biology (MCDB) Professor and Chief Scientific Officer of the Biofrontiers Institute at the University of Colorado Boulder. She is a co-founder of the University of Colorado Cardiovascular Institute and a co-founder of Myogen, Inc. and Hiberna, Inc.  At the University of Colorado she has served as Chair of the Molecular, Cellular, and Developmental Biology Department, Director of the Linda Crnic Institute for Down Syndrome, and Director of the Colorado Institute of Molecular Biotechnology. Prior to moving to Colorado, Dr. Leinwand was a Professor and Director of the Cardiovascular Research Center at Albert Einstein College of Medicine in New York.

Dr. Leinwand received her Bachelor’s degree from Cornell University, her PhD from Yale University, and was a Postdoctoral fellow at Rockefeller University.

Her research interests include the genetic manipulation of cardiac and skeletal muscle development and function in mice, gene therapy, and cardiac genetic disease.

Lynn Nadel, Ph.D.

Lynn Nadel, Regent's Professor of Psychology and a member of the Evelyn F. McKnight Brain Institute at The University of Arizona. He previously was Chair of the department of Psychology at the University of Arizona and is currently a Fellow of the American Association for the Advancement of Science and the American Psychological Society. He has held faculty positions at the University of California's Irvine and San Diego campuses and Dalhousie University in Nova Scotia.

Dr. Nadel received his doctorate in physiological psychology from McGill University and has held National Institute of Mental Health fellowships at the Czechoslovak Academy of Science in Prague and at University College London.

He is a leader in the field of brain mapping and establishing the critical importance of the hippocampus in memory and spatial cognition. His research has also focused on memory consolidation and reconsolidation, the effects of stress and sleep on memory and cognitive impairment in Down syndrome.

Roger Reeves, Ph.D.

Roger Reeves, Ph.D. is a Professor in the Department of Physiology and the McKusick-Nathans Institute of Genetic Medicine at The Johns Hopkins University School of Medicine.

Dr. Reeves received his undergraduate B.S. degree at Bowling Green State University, his
Ph.D. at the University of Maryland and the National Cancer Institute.  He completed his
Postdoctoral Fellowship at The Johns Hopkins University.

His research focuses on the mechanisms of gene action in Down syndrome and has contributed to significant breakthroughs in the field of Down syndrome cognitive research.

Andre' Strydom, MBChB, Ph.D.  

Andre Strydom' is Senior Clinical Lecturer in the Intellectual Disabilities and Mental Health Science Unit at University College, London. His research focuses on cognition and behavior in intellectual disabilities, including Down syndrome.